MAPLE GROVE, Minn., Aug. 15, 2016 /PRNewswire/ — Conventus Orthopaedics, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new Conventus Cage™ DU (Distal Ulna) and PU (Proximal Ulna) Systems, designed as innovative solutions to address fracture repairs of the ulnar bone. These new implants, the fourth […]